Wendyl D'Souza
Wendyl D'Souza is an expert in Neurology at St Vincent's Hospital (Australia). As of October 2026, ScienceLeadR ranks Wendyl D'Souza in the top 1% of experts worldwide for Epilepsy and Seizures. Wendyl D'Souza has authored 184 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 535 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Public Health - Immunology - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 184
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Early neurocognitive outcomes following SEEG with radiofrequency thermocoagulation. PMID 42897841 — neuropsychology, epilepsy, language, electrocoagulation, neuropsychological tests, telemedicine, recycling, work, counseling, cognition | Epilepsia Open | 2026 | 0 |
| Acute and longitudinal magnetic resonance imaging abnormalities in antibody-mediated encephalitis. PMID 42318510 — sclerosis, atrophy, magnetic resonance imaging, encephalitis, hippocampal sclerosis | Brain Commun | 2026 | 1 |
| Investigation of stress hormones across multiday seizure cycles. PMID 42311452 — epilepsy, stress, physiological, hormones, seizures, hydrocortisone | Brain Commun | 2026 | 2 |
| Plasma proteome in LGI-1 autoimmune encephalitis. PMID 42157263 — cells, genes, monocytes, autophagy, cognitive dysfunction, complement system proteins, therapeutics, proteome, encephalitis, plasma | J Neuroinflammation | 2026 | 0 |
| Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortium. PMID 41832838 — multiple sclerosis, executive function, encephalitis | Mult Scler Relat Disord | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| BMB 101 in Absence Epilepsy and DEE NCT06401538 — epilepsy, safety, eyelids, absenteeism, epilepsy, absence, lennox gastaut syndrome, epilepsies, myoclonic, brain diseases, dravet syndrome | Phase 2 | Recruiting | 2024 |
LeadR Networks
Main global connection map